Featured Research

from universities, journals, and other organizations

Reassurance for dementia sufferers on impact of common drugs

Date:
October 15, 2011
Source:
University of East Anglia
Summary:
Researchers whose findings on the detrimental impact of some common medicines on elderly people were widely reported earlier in the summer have found that taking a few of these medicines does not appear to cause further cognitive impairment in those already suffering from dementia.

Researchers whose findings on the detrimental impact of some common medicines on elderly people were widely reported earlier in the summer have found that taking a few of these medicines does not appear to cause further cognitive impairment in those already suffering from dementia.

In a paper published in the journal Age and Ageing, Dr Chris Fox of the University of East Anglia (UEA) and colleagues from a number of other universities and the NHS describe how they studied a clinically representative sample of 224 people with established Alzheimer's dementia who were taking low levels of these medicines.

In their earlier paper published by the Journal of the American Geriatrics Society on June 24, 2011, the team identified that an effect of many common and apparently quite disparate medicines appeared to increase the risks of both cognitive impairment and death in older people. These prescription and over-the-counter medicines, which range from antidepressants to some antihistamines, affect the brain by reducing the action of a key neurotransmitter called acetylcholine. This is known as an anticholinergic effect.

Older people are at higher risk of exposure to medications with anticholinergic effects because they are more likely to be regular users of prescription drugs. Up to 50 per cent of dementia patients in the US are estimated to take at least one such medication and similar levels were found in the earlier study.

"We found that taking a low dose of one medication with a low degree of anticholinergic activity does not appear to lead to more impaired cognition or a more rapid cognitive decline in people with dementia over the next six or 18 months," said study leader Dr Chris Fox of Norwich Medical School at UEA.

"We hope that this will provide some reassurance to families and carers of those with dementia. But we remain concerned about the impact on frail older people who have no signs or mild signs of impaired cognition before they start to take the drugs and we feel more work is needed in this area. In addition, we need studies on mortality in the more advanced dementia with these medicines."

Ian Maidment from the University of Kent said: "One possible explanation for the different results is that in people with dementia the cholinergic system is already impaired and therefore introducing a further insult, to the cholinergic system, has little effect. These results do, however, highlight the complexity of the issue and the need for further in-depth research."

Further research is also needed on the use of the scale as a predictor of cognitive impairment in older people. The scale covers representative medication, but does not currently take medication dosage into account and the researchers conclude that there is a need to assess the impact of medication doses.

The paper is authored by Chris Fox (University of East Anglia), Gill Livingston (University College London), Ian Maidment (Centre for Health Service Studies, University of Kent), Simon Coulton (Centre for Health Service Studies, University of Kent), David Smithard (Kent NHS Community Trust and Kent Comprehensive Research Network), Malaz Boustani (Indiana University Center for Aging Research and the Regenstrief institute), and Cornelius Katona (University College London). It appears Sept. 19, 2011 in Age and Ageing.

The study is part of a larger longitudinal cohort study of 224 participants with Alzheimer's Dementia (the London and South East Region Alzheimer's Dementia -- or LASER-AD -- study).


Story Source:

The above story is based on materials provided by University of East Anglia. Note: Materials may be edited for content and length.


Journal Reference:

  1. Chris Fox, Gill Livingston, Ian D. Maidment, Simon Coulton, David G. Smithard, Malaz Boustani, Cornelius Katona. The impact of anticholinergic burden in Alzheimer's Dementia-the Laser-AD study. Age and Ageing, 2011; DOI: 10.1093/ageing/afr102

Cite This Page:

University of East Anglia. "Reassurance for dementia sufferers on impact of common drugs." ScienceDaily. ScienceDaily, 15 October 2011. <www.sciencedaily.com/releases/2011/09/110918193028.htm>.
University of East Anglia. (2011, October 15). Reassurance for dementia sufferers on impact of common drugs. ScienceDaily. Retrieved September 1, 2014 from www.sciencedaily.com/releases/2011/09/110918193028.htm
University of East Anglia. "Reassurance for dementia sufferers on impact of common drugs." ScienceDaily. www.sciencedaily.com/releases/2011/09/110918193028.htm (accessed September 1, 2014).

Share This




More Mind & Brain News

Monday, September 1, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Coffee Then Napping: The (New) Key To Alertness

Coffee Then Napping: The (New) Key To Alertness

Newsy (Aug. 30, 2014) Researchers say having a cup of coffee then taking a nap is more effective than a nap or coffee alone. Video provided by Newsy
Powered by NewsLook.com
Young Entrepreneurs Get $100,000, If They Quit School

Young Entrepreneurs Get $100,000, If They Quit School

AFP (Aug. 29, 2014) Twenty college-age students are getting 100,000 dollars from a Silicon Valley leader and a chance to live in San Francisco in order to work on the start-up project of their dreams, but they have to quit school first. Duration: 02:20 Video provided by AFP
Powered by NewsLook.com
Baby Babbling Might Lead To Faster Language Development

Baby Babbling Might Lead To Faster Language Development

Newsy (Aug. 29, 2014) A new study suggests babies develop language skills more quickly if their parents imitate the babies' sounds and expressions and talk to them often. Video provided by Newsy
Powered by NewsLook.com
Electrical Stimulation Boosts Brain Function, Study Says

Electrical Stimulation Boosts Brain Function, Study Says

Newsy (Aug. 29, 2014) Researchers found an improvement in memory and learning function in subjects who received electric pulses to their brains. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins